Ambu A/S (OTCMKTS:AMBBY) Shares Up 13.4% – Here’s What Happened

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY)’s share price rose 13.4% during mid-day trading on Wednesday. The stock traded as high as $13.20 and last traded at $13.20. Approximately 101 shares changed hands during trading, a decline of 85% from the average session volume of 655 shares. The stock had previously closed at $11.64.

Analysts Set New Price Targets

Separately, UBS Group downgraded shares of Ambu A/S from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 15th. One investment analyst has rated the stock with a Hold rating. Based on data from MarketBeat, Ambu A/S currently has an average rating of “Hold”.

Ambu A/S Stock Up 9.1%

The firm has a market cap of $3.10 billion, a PE ratio of 44.00 and a beta of 0.86. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.69 and a current ratio of 2.77. The firm’s 50-day moving average price is $11.01 and its two-hundred day moving average price is $11.00.

Ambu A/S (OTCMKTS:AMBBY) last posted its earnings results on Tuesday, August 25th. The company reported $0.09 EPS for the quarter. Ambu A/S had a net margin of 8.18% and a return on equity of 8.49%. The firm had revenue of $255.12 million for the quarter.

About Ambu A/S

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.